Similar articles

• Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity.

  Ferguson RK, Vlasses PH, Koplin JR, Holmes GI, Huber P, Demetriades J, Abrams WB. Ferguson RK, et al. Br J Clin Pharmacol. 1982 Nov;14(5):719-25. doi: 10.1111/j.1365-2125.1982.tb04963.x. Br J Clin Pharmacol. 1982. PMID: 6128021 Free PMC article. Clinical Trial.
• Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.

  Ishizaki T, Tawara K. Ishizaki T, et al. Eur J Clin Pharmacol. 1978 Nov 9;14(1):7-14. doi: 10.1007/BF00560252. Eur J Clin Pharmacol. 1978. PMID: 32043
• Beta-blockade, renin and blood-pressure.

  Weber MA, Drayer JI, Laragh JH. Weber MA, et al. Lancet. 1977 Feb 12;1(8007):367-8. doi: 10.1016/s0140-6736(77)91173-4. Lancet. 1977. PMID: 64892 No abstract available.
• Beta-blockers and the kidney.

  Epstein M, Oster JR. Epstein M, et al. Miner Electrolyte Metab. 1982 Nov;8(5):237-54. Miner Electrolyte Metab. 1982. PMID: 6132329 Review. No abstract available.
• Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.

  Man in't Veld AJ, Schalekamp MA. Man in't Veld AJ, et al. Postgrad Med J. 1983;59 Suppl 3(689):140-58. Postgrad Med J. 1983. PMID: 6139800 Free PMC article. Review.